Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI-CACI 2021 | Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease

✔️ Watch again the session “Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease” in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

  • 02:27 – Computer Tomography in TAVR: Planning, Predicting Complications, and Follow-up – Mariano Falconi
  • 19:26 – Multi-Imaging Evaluation in Mitral Regurgitation Intervention – Fabián Salmo
  • 31:10 – New Prognosis Tools in Cardiac CT: Beyond Stenosis – Gastón Rodríguez Granillo
  • 48:32 – Understanding Phenotypical Differences Between Genders in Chronic Coronary Syndromes – Roxana Campisi
  • 01:03:20 – Role of Coronary CT for Guiding Complex Procedures: CTO and CHIP – Hector García García

👉🏻 Panelists: Cerda, Miguel – De Quadros, Alexandre S. – Fernández, Mario – Fernández-Pereira, Carlos – Ingino, Carlos – Larraburu, Alfredo – Sciancalepore, Agustina
👉🏻 Chairpersons: Diego Pérez de Arenaza & Aníbal Damonte
👉🏻 Digital Moderator: Marcelo Halac


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...